Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
Clinical trial NCT00120861 · COMPLETED
Trial details
- NCT number
- NCT00120861
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.